• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.

机构信息

Department of Medicine, University of Padova, Italy.

Department of Medicine, University of Padova, Italy.

出版信息

Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.

DOI:10.1016/j.diabres.2020.108374
PMID:32805345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7428425/
Abstract

AIMS

We investigated whether pre-existing diabetes, newly-diagnosed diabetes, and admission hyperglycemia were associated with COVID-19 severity independently from confounders.

METHODS

We retrospectively analyzed data on patients with COVID-19 hospitalized between February and April 2020 in an outbreak hospital in North-East Italy. Pre-existing diabetes was defined by self-reported history, electronic medical records, or ongoing medications. Newly-diagnosed diabetes was defined by HbA1c and fasting glucose. The primary outcome was a composite of ICU admission or death.

RESULTS

413 subjects were included, 107 of whom (25.6%) had diabetes, including 21 newly-diagnosed. Patients with diabetes were older and had greater comorbidity burden. The primary outcome occurred in 37.4% of patients with diabetes compared to 20.3% in those without (RR 1.85; 95%C.I. 1.33-2.57; p < 0.001). The association was stronger for newly-diagnosed compared to pre-existing diabetes (RR 3.06 vs 1.55; p = 0.004). Higher glucose level at admission was associated with COVID-19 severity, with a stronger association among patients without as compared to those with pre-existing diabetes (interaction p < 0.001). Admission glucose was correlated with most clinical severity indexes and its association with adverse outcome was mostly mediated by a worse respiratory function.

CONCLUSION

Newly-diagnosed diabetes and admission hyperglycemia are powerful predictors of COVID-19 severity due to rapid respiratory deterioration.

摘要

目的

我们旨在研究是否在排除混杂因素后,预先存在的糖尿病、新诊断的糖尿病和入院高血糖与 COVID-19 严重程度有关。

方法

我们回顾性分析了 2020 年 2 月至 4 月期间在意大利东北部一家暴发医院住院的 COVID-19 患者的数据。预先存在的糖尿病通过自我报告的病史、电子病历或正在服用的药物来定义。新诊断的糖尿病通过 HbA1c 和空腹血糖来定义。主要结局是 ICU 入院或死亡的复合结局。

结果

共纳入 413 例患者,其中 107 例(25.6%)患有糖尿病,包括 21 例新诊断的糖尿病。患有糖尿病的患者年龄更大,合并症负担更重。患有糖尿病的患者中主要结局的发生率为 37.4%,而无糖尿病的患者中主要结局的发生率为 20.3%(RR 1.85;95%CI 1.33-2.57;p<0.001)。与预先存在的糖尿病相比,新诊断的糖尿病与 COVID-19 严重程度的相关性更强(RR 3.06 比 1.55;p=0.004)。入院时的血糖水平与 COVID-19 严重程度相关,在无预先存在的糖尿病的患者中相关性更强(交互作用 p<0.001)。入院血糖与大多数临床严重程度指标相关,其与不良结局的相关性主要通过更差的呼吸功能来介导。

结论

新诊断的糖尿病和入院高血糖是 COVID-19 严重程度的有力预测因素,这是由于呼吸功能迅速恶化所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/7428425/4d1217fa8dd7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/7428425/89f1305e8c54/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/7428425/ebc5bbe47225/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/7428425/4d1217fa8dd7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/7428425/89f1305e8c54/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/7428425/ebc5bbe47225/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/7428425/4d1217fa8dd7/gr3_lrg.jpg

相似文献

1
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.新诊断的糖尿病和入院时的高血糖通过加重呼吸恶化预测 COVID-19 的严重程度。
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
2
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.空腹血糖受损和糖尿病与 2019 冠状病毒病患者的并发症和死亡率升高相关。
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
3
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.入院时高血糖与 COVID-19 住院患者预后严重程度相关:比萨 COVID-19 研究。
Diabetes Care. 2020 Oct;43(10):2345-2348. doi: 10.2337/dc20-1380. Epub 2020 Aug 11.
4
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.高血糖而无糖尿病和新发糖尿病均与 COVID-19 的预后不良相关。
Diabetes Res Clin Pract. 2020 Sep;167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.
5
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.美国住院新冠病毒疾病(COVID-19)患者的血糖特征及临床结局
J Diabetes Sci Technol. 2020 Jul;14(4):813-821. doi: 10.1177/1932296820924469. Epub 2020 May 9.
6
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.意大利米兰新冠疫情临床结局的早期预测指标。
Clin Immunol. 2020 Aug;217:108509. doi: 10.1016/j.clim.2020.108509. Epub 2020 Jun 12.
7
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection.国家早期预警评分 2(NEWS2)对 SARS-CoV-2 感染患者入住重症监护病房的预测价值。
Infect Dis (Lond). 2020 Oct;52(10):698-704. doi: 10.1080/23744235.2020.1784457. Epub 2020 Jun 25.
8
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?糖尿病是否是 2019 年冠状病毒病(COVID-19)的危险因素?
Acta Diabetol. 2020 Nov;57(11):1275-1285. doi: 10.1007/s00592-020-01586-6. Epub 2020 Aug 31.
9
Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients.《重症监护病房患者高血糖与 SARS-CoV-2 感染的临床研究》
In Vivo. 2020 Sep-Oct;34(5):3029-3032. doi: 10.21873/invivo.12136.
10
Hyperglycemia is a strong predictor of poor prognosis in COVID-19.高血糖是 COVID-19 预后不良的一个强有力的预测指标。
Diabetes Res Clin Pract. 2020 Sep;167:108338. doi: 10.1016/j.diabres.2020.108338. Epub 2020 Jul 24.

引用本文的文献

1
Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study.哥伦比亚新冠肺炎重症监护病房住院患者的高血糖、糖尿病和新发糖尿病:一项纵向队列研究的结果
J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):257-264. doi: 10.2478/jccm-2025-0026. eCollection 2025 Jul.
2
Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trial.新型冠状病毒肺炎合并严重低氧血症患者使用高血糖素和胰岛素时给予12毫克与6毫克地塞米松的疗效比较:COVID STEROID 2随机试验的二次分析
Ann Intensive Care. 2025 Jul 15;15(1):98. doi: 10.1186/s13613-025-01512-5.
3

本文引用的文献

1
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
2
Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City.肥胖与 COVID-19 患者的不良结局相关:来自纽约市早期数据的分析。
Obesity (Silver Spring). 2020 Sep;28(9):1606-1612. doi: 10.1002/oby.22923.
3
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
Diabetes Mellitus and Multidrug-Resistant Gram-Negative Bacterial Infections in Critically Ill COVID-19 Patients: A Retrospective Observational Study.危重症COVID-19患者的糖尿病与多重耐药革兰氏阴性菌感染:一项回顾性观察研究
Diagnostics (Basel). 2025 May 8;15(10):1190. doi: 10.3390/diagnostics15101190.
4
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19.糖尿病范围内的高血糖,而非先前的糖尿病诊断,是因重症COVID-19住院患者预后不良的独立指标。
Acta Diabetol. 2025 May 2. doi: 10.1007/s00592-025-02507-1.
5
The impact of insulin requirement on mortality and morbidity in non-diabetic covid-19 patients in the intensive care unit: A retrospective, observational study.胰岛素需求对重症监护病房非糖尿病新冠患者死亡率和发病率的影响:一项回顾性观察研究。
BMC Anesthesiol. 2025 Apr 9;25(1):160. doi: 10.1186/s12871-025-03037-7.
6
Economic impact of COVID-19 on patients with type 2 diabetes in Kenya and Tanzania: a costing analysis.2019年冠状病毒病对肯尼亚和坦桑尼亚2型糖尿病患者的经济影响:成本分析
BMJ Public Health. 2024 Aug 24;2(2):e000383. doi: 10.1136/bmjph-2023-000383. eCollection 2024 Dec.
7
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study.慢性HBV感染合并COVID-19肺炎住院患者的临床特征与转归:一项回顾性队列研究
Viruses. 2024 Dec 30;17(1):40. doi: 10.3390/v17010040.
8
Signaling Pathways (TNF-α-NF-κB, TLR2-TLR4 as well as ROS-MDA) and Cardiac Damages during Cardiac Surgeries (Coronary Stenting, Permanent Pacemaker Implantations, Radiofrequency Ablations).心脏手术(冠状动脉支架置入术、永久性起搏器植入术、射频消融术)期间的信号通路(肿瘤坏死因子-α-核因子-κB、Toll样受体2-Toll样受体4以及活性氧-丙二醛)与心脏损伤
Curr Top Med Chem. 2025;25(2):196-208. doi: 10.2174/0115680266314899240919081451.
9
The relationship between COVID-19 and hyperglycemia: screening and monitoring hospitalized patients.新型冠状病毒肺炎与高血糖之间的关系:住院患者的筛查与监测
Clin Diabetes Endocrinol. 2024 Aug 31;10(1):29. doi: 10.1186/s40842-024-00184-7.
10
Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells.高血糖对胰腺β细胞中 SARS-CoV-2 进入机制的潜在影响。
Viruses. 2024 Aug 2;16(8):1243. doi: 10.3390/v16081243.
新诊断的糖尿病与 COVID-19 住院患者的已知糖尿病相比,与死亡率升高相关。
Diabetes Obes Metab. 2020 Oct;22(10):1897-1906. doi: 10.1111/dom.14099. Epub 2020 Jun 30.
4
The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.糖尿病微血管病变对 COVID-19 不良结局的影响。
Diabetes Res Clin Pract. 2020 Jun;164:108217. doi: 10.1016/j.diabres.2020.108217. Epub 2020 May 13.
5
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes.新冠病毒疾病(COVID-19)症状掩盖了1型糖尿病的首次酮症酸中毒。
Diabetes Metab. 2021 Feb;47(1):101162. doi: 10.1016/j.diabet.2020.05.004. Epub 2020 May 21.
6
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?COVID-19 影响下的高血糖患者结局:我们能否在血糖控制方面做得更好?
Diabetes Care. 2020 Jul;43(7):1408-1415. doi: 10.2337/dc20-0723. Epub 2020 May 19.
7
The diabetic lung: An easy target for SARS-CoV-2?糖尿病患者的肺部:是否是新冠病毒的易侵袭目标?
Diabetes Metab Res Rev. 2020 Nov;36(8):e3346. doi: 10.1002/dmrr.3346. Epub 2020 Jun 18.
8
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素:一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.
9
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
10
COVID-19 cytokine storm: the interplay between inflammation and coagulation.新型冠状病毒肺炎细胞因子风暴:炎症与凝血之间的相互作用
Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27.